Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Stasi

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Blood|October 25, 2011
ITP, interruptedRoberto Stasi
Blood|May 28, 2011
The stingy bone marrow and the wasteful peripheral blood: a tale of two ITPsRoberto Stasi
European Journal of Haematology. Supplementum|February 10, 2009
Immune thrombocytopenic purpura: the treatment paradigmRoberto Stasi
Current Opinion in Molecular Therapeutics|December 15, 2010
Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpuraRoberto Stasi
Expert Review of Hematology|November 19, 2010
Eltrombopag for the treatment of idiopathic thrombocytopenic purpuraRoberto Stasi
Expert Opinion on Biological Therapy|March 21, 2008
Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemiaRoberto Stasi
Hematology. American Society of Hematology. Education Program|December 13, 2012
How to approach thrombocytopeniaRoberto Stasi
Expert Opinion on Drug Discovery|March 14, 2013
Eltrombopag: the discovery of a second generation thrombopoietin-receptor agonistRoberto Stasi
Seminars in Hematology|February 28, 2009
Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopeniasRoberto Stasi
Seminars in Thrombosis and Hemostasis|July 4, 2012
Immune thrombocytopenia: pathophysiologic and clinical updateRoberto Stasi
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Blood|October 25, 2011
ITP, interruptedRoberto Stasi
Blood|May 28, 2011
The stingy bone marrow and the wasteful peripheral blood: a tale of two ITPsRoberto Stasi
European Journal of Haematology. Supplementum|February 10, 2009
Immune thrombocytopenic purpura: the treatment paradigmRoberto Stasi
Current Opinion in Molecular Therapeutics|December 15, 2010
Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpuraRoberto Stasi
Expert Review of Hematology|November 19, 2010
Eltrombopag for the treatment of idiopathic thrombocytopenic purpuraRoberto Stasi
Expert Opinion on Biological Therapy|March 21, 2008
Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemiaRoberto Stasi
Hematology. American Society of Hematology. Education Program|December 13, 2012
How to approach thrombocytopeniaRoberto Stasi
Expert Opinion on Drug Discovery|March 14, 2013
Eltrombopag: the discovery of a second generation thrombopoietin-receptor agonistRoberto Stasi
Seminars in Hematology|February 28, 2009
Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopeniasRoberto Stasi
Seminars in Thrombosis and Hemostasis|July 4, 2012
Immune thrombocytopenia: pathophysiologic and clinical updateRoberto Stasi
Pageof 9